# Intraperitoneal LSTA1 in CRS-HIPEC

> **NCT06216561** · PHASE1 · WITHDRAWN · sponsor: **University of California, San Diego**

## Conditions studied

- Colorectal Cancer
- Ovarian Carcinoma
- Appendix Cancer
- Peritoneal Metastases

## Interventions

- **DRUG:** CRS-HIPEC + LSTA1
- **PROCEDURE:** CRS-HIPEC alone

## Key facts

- **NCT ID:** NCT06216561
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-11-30
- **Primary completion:** 2024-06-24
- **Final completion:** 2024-06-24
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** closed early due to low (0) accrual
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06216561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06216561, "Intraperitoneal LSTA1 in CRS-HIPEC". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06216561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*